C-X-C chemokine receptor type 3
CXCR3proteinCXCR3 transduces chemokine signals recruiting inflammatory Th1 cells and monocytes to destabilize plaques.
Pathway placement
Cascade stepPlaque inflammation
Confidencehigh
RationaleCXCL10 receptor mediating Th1/leukocyte recruitment and atherosclerotic plaque inflammation.
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000186810
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I38
C — confounder / Type-II68
A — assay feasibility68
E — evidence strength25
T1DI (composite)6
Specificity differential (R−C)-29.6
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(3)
- Genetic Variation in the Chemokine Network and Atherosclerosis Risk.Current atherosclerosis reports · 2026 · PMID 41824188 · doi
- Single-cell transcriptomic analysis of peripheral blood mononuclear cells reveals key immune responses in ST-segment elevation myocardial infarction.Hereditas · 2025 · PMID 41291938 · doi
- The multifaceted functions of CXCL10 in cardiovascular disease.BioMed research international · 2014 · PMID 24868552 · doi